What to do with our T1b esophageal adenocarcinoma patients?
暂无分享，去创建一个
[1] G. Ginsberg,et al. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. , 2020, Gastrointestinal endoscopy.
[2] J. Bergman,et al. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma , 2018, United European gastroenterology journal.
[3] S. Meijer,et al. Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease , 2016, Surgical Endoscopy.
[4] M. Vieth,et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns , 2015, Surgical Endoscopy.
[5] L. Gossner,et al. Early Barrett's Carcinoma With “Low-Risk” Submucosal Invasion: Long-Term Results of Endoscopic Resection With a Curative Intent , 2008, The American Journal of Gastroenterology.
[6] B. Weusten,et al. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease , 2016, Surgical Endoscopy.